NUVB - Nuvation Bio GAAP EPS of -$0.12 beats by $0.02 November, 03 2022 05:25 PM Nuvation Bio Inc. Class A Nuvation Bio press release ( NYSE: NUVB ): Q3 GAAP EPS of -$0.12 beats by $0.02 . Strong financial position provides cash runway through 2028; cash, cash equivalents and marketable securities of $673.9M as of September 30, 2022. For further details see: Nuvation Bio GAAP EPS of -$0.12 beats by $0.02